检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Brentuximab vedotin in refractory or relapsed Peripheral T-cell Lymphomas: The French named patient program experience in 56 patients

Mathilde Lamarque,Celine Bossard,Adrien Contejean,Pauline Brice,Marie Parrens,Steven Le Gouill,Josette Briere,Reda Bouabdallah,Danielle Canioni,Herve Tilly,Brigitte Bouchindhomme,Emmanuel Bachy,Richard Delarue,Corinne Haioun,Philippe Gaulard

HAEMATOLOGICA（2016）

引用 33|浏览19
暂无评分
关键词
brentuximab vedotin,relapsed,refractory,systemic anaplastic large-cell lymphoma,primary cutaneous T-cell lymphoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要